225 related items for PubMed ID: 21928226
21. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.
Basu B, Babu BG, Mahapatra TK.
Clin Exp Nephrol; 2017 Feb; 21(1):143-151. PubMed ID: 27108294
[Abstract] [Full Text] [Related]
22. Behavioural abnormalities in children with nephrotic syndrome.
Mishra OP, Basu B, Upadhyay SK, Prasad R, Schaefer F.
Nephrol Dial Transplant; 2010 Aug; 25(8):2537-41. PubMed ID: 20200003
[Abstract] [Full Text] [Related]
23. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P.
Nephrol Dial Transplant; 1993 Aug; 8(12):1326-32. PubMed ID: 8159300
[Abstract] [Full Text] [Related]
24. Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.
Abeyagunawardena AS, Thalgahagoda RS, Dissanayake PV, Abeyagunawardena S, Illangasekera YA, Karunadasa UI, Trompeter RS.
Pediatr Nephrol; 2017 Aug; 32(8):1377-1382. PubMed ID: 28341877
[Abstract] [Full Text] [Related]
25. Long-term follow-up study of IgM associated nephrotic syndrome patients: clinical outcome and prognostic indicators.
Kurathong P, Jesdapatarakul S.
J Med Assoc Thai; 2000 Mar; 83(3):315-24. PubMed ID: 10808687
[Abstract] [Full Text] [Related]
26. Adrenal function after prednisolone treatment in childhood nephrotic syndrome.
Sumboonnanonda A, Vongjirad A, Suntornpoch V, Petrarat S.
J Med Assoc Thai; 1994 Mar; 77(3):126-9. PubMed ID: 7798846
[Abstract] [Full Text] [Related]
27. Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children.
Raja K, Parikh A, Webb H, Hothi D.
Pediatr Nephrol; 2017 Jan; 32(1):99-105. PubMed ID: 27677978
[Abstract] [Full Text] [Related]
28. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
Sinha MD, MacLeod R, Rigby E, Clark AG.
Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257
[Abstract] [Full Text] [Related]
29. Incidence and risk factors of relapses in idiopathic autoimmune hemolytic anemia.
Dussadee K, Taka O, Thedsawad A, Wanachiwanawin W.
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S165-70. PubMed ID: 20364571
[Abstract] [Full Text] [Related]
30. [Long-term outcome of children treated with the ISKDC regimen for the first episode of INS].
Hirano D, Nishizaki N, Kanai H, Hara S, Ohtomo Y, Umino D, Fujinaga S.
Nihon Jinzo Gakkai Shi; 2010 Jan; 52(8):1029-36. PubMed ID: 21254699
[Abstract] [Full Text] [Related]
31. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[Abstract] [Full Text] [Related]
32. Zinc supplement in reduction of relapses in children with steroid sensitive nephrotic syndrome.
Sherali AR, Moorani KN, Chishty SH, Khan SI.
J Coll Physicians Surg Pak; 2014 Feb; 24(2):110-3. PubMed ID: 24491005
[Abstract] [Full Text] [Related]
33. Effect of levamisole in steroid-dependent nephrotic syndrome.
Madani A, Isfahani ST, Rahimzadeh N, Fereshtehnejad SM, Hoseini R, Moghtaderi M, Mohseni P, Ataiee N.
Iran J Kidney Dis; 2010 Oct; 4(4):292-6. PubMed ID: 20852369
[Abstract] [Full Text] [Related]
34. Comparative study of angiotensin converting enzyme inhibitor and calcium channel blocker in the treatment of steroid-resistant idiopathic nephrotic syndrome.
Kumar NS, Singh AK, Mishra RN, Prakash J.
J Assoc Physicians India; 2004 Jun; 52():454-8. PubMed ID: 15645954
[Abstract] [Full Text] [Related]
35. Older boys benefit from higher initial prednisolone therapy for nephrotic syndrome. The West Japan Cooperative Study of Kidney Disease in Children.
Hiraoka M, Tsukahara H, Haruki S, Hayashi S, Takeda N, Miyagawa K, Okuhara K, Suehiro F, Ohshima Y, Mayumi M.
Kidney Int; 2000 Sep; 58(3):1247-52. PubMed ID: 10972687
[Abstract] [Full Text] [Related]
36. [Initial therapy of primary nephrotic syndrome in children: evaluation in a period of 18 months of two prednisone treatment schedules. Chilean Co-operative Group of Study of Nephrotic Syndrome in Children].
Norero C, Delucchi A, Lagos E, Rosati P.
Rev Med Chil; 1996 May; 124(5):567-72. PubMed ID: 9035508
[Abstract] [Full Text] [Related]
37. Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine.
Hino S, Takemura T, Okada M, Murakami K, Yagi K, Fukushima K, Yoshioka K.
Am J Kidney Dis; 1998 Jun; 31(6):932-9. PubMed ID: 9631836
[Abstract] [Full Text] [Related]
38. Follow-up of linear growth of body height in children with nephrotic syndrome.
Hung YT, Yang LY.
J Microbiol Immunol Infect; 2006 Oct; 39(5):422-5. PubMed ID: 17066206
[Abstract] [Full Text] [Related]
39. Steroid responsiveness of children with idiopathic nephrotic syndrome in southeastern region of Turkey.
Davutoglu M, Ece A, Bilici M, Dagli A.
Ren Fail; 2007 Oct; 29(7):855-9. PubMed ID: 17994455
[Abstract] [Full Text] [Related]
40. Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome.
Teeninga N, Kist-van Holthe JE, van Rijswijk N, de Mos NI, Hop WC, Wetzels JF, van der Heijden AJ, Nauta J.
J Am Soc Nephrol; 2013 Jan; 24(1):149-59. PubMed ID: 23274956
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
